rs2228990
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP7BA1
The NM_001094.5(ASIC2):c.315T>C(p.Asn105Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 1,613,928 control chromosomes in the GnomAD database, including 38,440 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001094.5 synonymous
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001094.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ASIC2 | TSL:1 | c.315T>C | p.Asn105Asn | synonymous | Exon 1 of 10 | ENSP00000352934.6 | Q16515-1 | ||
| ENSG00000263571 | TSL:5 | n.653A>G | non_coding_transcript_exon | Exon 1 of 4 | |||||
| ENSG00000263571 | n.605A>G | non_coding_transcript_exon | Exon 1 of 3 |
Frequencies
GnomAD3 genomes AF: 0.215 AC: 32739AN: 151966Hom.: 3788 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.246 AC: 61499AN: 249508 AF XY: 0.242 show subpopulations
GnomAD4 exome AF: 0.210 AC: 307499AN: 1461842Hom.: 34647 Cov.: 33 AF XY: 0.212 AC XY: 153970AN XY: 727222 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.215 AC: 32772AN: 152086Hom.: 3793 Cov.: 32 AF XY: 0.222 AC XY: 16502AN XY: 74362 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.